Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-082634
Filing Date
2024-07-25
Accepted
2024-07-25 16:10:57
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 tm2420042-1_s3.htm S-3 308312
2 EXHIBIT 4.1 tm2420042d2_ex4-1.htm EX-4.1 293508
3 EXHIBIT 5.1 tm2420042d2_ex5-1.htm EX-5.1 13016
4 EXHIBIT 23.1 tm2420042d2_ex23-1.htm EX-23.1 1974
5 EX-FILING FEES tm2420042d2_ex-filingfees.htm EX-FILING FEES 22143
6 GRAPHIC tm2420042d2_ex5-1img001.jpg GRAPHIC 5072
7 GRAPHIC tm2420042d2_ex5-1img002.gif GRAPHIC 8773
8 GRAPHIC lg_kalabio-4clr.jpg GRAPHIC 9246
  Complete submission text file 0001104659-24-082634.txt   672328
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Filer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-281006 | Film No.: 241142172
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)